Skip to main content

CITADEL ADVISORS LLC

Position in VANI — Vivani Medical, Inc.

CIK 1423053 MIAMI, FL

Position in VANI

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$0
-$49,703 QoQ
Shares Held
0
-100.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Sep 2022
12 quarters on record

Common Shares in VANI Over Time

Shares Held

Position Value (USD)

Derivatives in VANI

reported options exposure · as of Mar 31, 2026
CallValue
$14,100
CallShares
14,100
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

CITADEL ADVISORS LLC holds $5,780,974,653 across 374 Biotechnology names.

# Ticker Company Shares Value (USD) Open

All Filings in VANI

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $14,100 14,100
2025-12-31 $13,530 11,000
2025-12-31 $49,703 40,409
2025-12-31 $55,104 44,800
2025-09-30 $25,896 18,366
2024-12-31 $12,669 10,922
2024-12-31 $8,236 7,100
2024-12-31 $18,444 15,900
2024-09-30 $20,124 17,200
2024-09-30 $9 8
2024-09-30 $9,360 8,000
2024-06-30 $14,616 11,600
2024-06-30 $44,982 35,700
2024-03-31 $37,000 20,000
2024-03-31 $118,030 63,800
2023-12-31 $11,029 10,813
2023-12-31 $7,605 7,456
2023-09-30 $201 198
2023-09-30 $10,086 9,889
2023-06-30 $239 198
2023-06-30 $12,570 10,389
2022-12-31 $10,018 11,787
2022-12-31 $68 80
2022-12-31 $1,178 1,387
2022-09-30 $55,492 24,339